Collectively, these findings suggest that ZnSO4 pretreatment activates GPR39, downregulates the SIRT1/FoxO1 pathway in T1D mice, and inhibits autophagy‐related factors. Here, FOXO1 is linked to type 1 diabetes mellitus.